Literature DB >> 25242279

Growing knowledge of the mTOR signaling network.

Kezhen Huang1, Diane C Fingar2.   

Abstract

The kinase mTOR (mechanistic target of rapamycin) integrates diverse environmental signals and translates these cues into appropriate cellular responses. mTOR forms the catalytic core of at least two functionally distinct signaling complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 promotes anabolic cellular metabolism in response to growth factors, nutrients, and energy and functions as a master controller of cell growth. While significantly less well understood than mTORC1, mTORC2 responds to growth factors and controls cell metabolism, cell survival, and the organization of the actin cytoskeleton. mTOR plays critical roles in cellular processes related to tumorigenesis, metabolism, immune function, and aging. Consequently, aberrant mTOR signaling contributes to myriad disease states, and physicians employ mTORC1 inhibitors (rapamycin and analogs) for several pathological conditions. The clinical utility of mTOR inhibition underscores the important role of mTOR in organismal physiology. Here we review our growing knowledge of cellular mTOR regulation by diverse upstream signals (e.g. growth factors; amino acids; energy) and how mTORC1 integrates these signals to effect appropriate downstream signaling, with a greater emphasis on mTORC1 over mTORC2. We highlight dynamic subcellular localization of mTORC1 and associated factors as an important mechanism for control of mTORC1 activity and function. We will cover major cellular functions controlled by mTORC1 broadly. While significant advances have been made in the last decade regarding the regulation and function of mTOR within complex cell signaling networks, many important findings remain to be discovered.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amino acids; Energy; Insulin; mTOR; mTORC1; mTORC2

Mesh:

Substances:

Year:  2014        PMID: 25242279      PMCID: PMC4253687          DOI: 10.1016/j.semcdb.2014.09.011

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  168 in total

Review 1.  Synthesis of the translational apparatus is regulated at the translational level.

Authors:  O Meyuhas
Journal:  Eur J Biochem       Date:  2000-11

2.  Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

Authors:  A C Gingras; B Raught; S P Gygi; A Niedzwiecka; M Miron; S K Burley; R D Polakiewicz; A Wyslouch-Cieszynska; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

3.  Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Authors:  Tzipora Shoshani; Alexander Faerman; Igor Mett; Elena Zelin; Tamar Tenne; Svetlana Gorodin; Yana Moshel; Shlomo Elbaz; Andrei Budanov; Ayelet Chajut; Hagar Kalinski; Iris Kamer; Ada Rozen; Orna Mor; Eli Keshet; Dena Leshkowitz; Paz Einat; Rami Skaliter; Elena Feinstein
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Phosphatidic acid-mediated mitogenic activation of mTOR signaling.

Authors:  Y Fang; M Vilella-Bach; R Bachmann; A Flanigan; J Chen
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro.

Authors:  S Isotani; K Hara; C Tokunaga; H Inoue; J Avruch; K Yonezawa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

6.  Regulation of cellular growth by the Drosophila target of rapamycin dTOR.

Authors:  H Zhang; J P Stallock; J C Ng; C Reinhard; T P Neufeld
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

7.  Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin.

Authors:  S Oldham; J Montagne; T Radimerski; G Thomas; E Hafen
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

8.  Identification of a conserved motif required for mTOR signaling.

Authors:  Stefanie S Schalm; John Blenis
Journal:  Curr Biol       Date:  2002-04-16       Impact factor: 10.834

9.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

Authors:  Diane C Fingar; Sofie Salama; Christina Tsou; Ed Harlow; John Blenis
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

10.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

View more
  126 in total

1.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

Review 2.  mTOR function and therapeutic targeting in breast cancer.

Authors:  Stephen H Hare; Amanda J Harvey
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

3.  GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.

Authors:  Hong Soon Kang; Dhirendra Kumar; Grace Liao; Kristin Lichti-Kaiser; Kevin Gerrish; Xiao-Hui Liao; Samuel Refetoff; Raja Jothi; Anton M Jetten
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

4.  Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.

Authors:  Ting-Ting Liu; Kai-Xia Yang; Jing Yu; Ying-Ya Cao; Jian-Song Ren; Jia-Jie Hao; Bei-Qing Pan; Sai Ma; Li-Yan Yang; Yan Cai; Ming-Rong Wang; Yu Zhang
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

5.  Stress and inflammatory gene networks in bovine liver are altered by plane of dietary energy during late pregnancy.

Authors:  M Jawad Khan; Carolina B Jacometo; Mario Vailati Riboni; Erminio Trevisi; Daniel E Graugnard; Marcio N Corrêa; Juan J Loor
Journal:  Funct Integr Genomics       Date:  2015-05-05       Impact factor: 3.410

6.  Role of mTOR complex in IGF-1 induced neural differentiation of DPSCs.

Authors:  Dan Huang; Shuling Shen; Ming Cai; Lin Jin; Jun Lu; Ke Xu; Jinlong Zhang; Guijuan Feng; Yingzi Hu; Ke Zheng; Xingmei Feng
Journal:  J Mol Histol       Date:  2019-05-02       Impact factor: 2.611

7.  The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Authors:  Jeanine L Van Nostrand; Alice Brisac; Stephano S Mello; Suzanne B R Jacobs; Richard Luong; Laura D Attardi
Journal:  Cancer Discov       Date:  2015-03-26       Impact factor: 39.397

Review 8.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

9.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

Review 10.  Mammalian target of rapamycin complex (mTOR) pathway modulates blood-testis barrier (BTB) function through F-actin organization and gap junction.

Authors:  Nan Li; C Yan Cheng
Journal:  Histol Histopathol       Date:  2016-03-09       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.